Neuroone Medical Technologies (NMTC) Raw Materials (2023)

Neuroone Medical Technologies (NMTC) posted Raw Materials of $1.0 million for Q4 2023, down 13.21% on a QoQ basis from $1.2 million in Q3 2023.

Neuroone Medical Technologies (NMTC) Raw Materials (2023) Analysis & Trends

Neuroone Medical Technologies' Raw Materials history runs 1 years deep, the most recent figure standing at $1.0 million for Q4 2023.

  • Quarterly Raw Materials changed N/A year-over-year to $1.0 million in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $1.0 million (changed N/A YoY) and the FY2023 annual result came in at $1.2 million, changed N/A from the prior year.
  • Raw Materials was $1.0 million for Q4 2023 at Neuroone Medical Technologies, down from $1.2 million in the prior quarter.
  • Across five years, Raw Materials topped out at $1.2 million in Q3 2023 and bottomed at $1.0 million in Q4 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn -
10 Neuroone Medical Technologies 7.99 Mn 5.19 Mn 990,264.00

Historic Data

Download Data
DateValue
Dec 31, 2023 1.04 Mn
Sep 30, 2023 1.20 Mn